Literature DB >> 9192824

Relationships between the mitochondrial permeability transition and oxidative stress during ara-C toxicity.

K L Backway1, E A McCulloch, S Chow, D W Hedley.   

Abstract

The mitochondrial permeability transition and oxidative stress seem to be critical alterations in cellular physiology that take place during programmed cell death. Failure to undergo apoptosis is associated with drug resistance in acute myeloid leukemia and other cancers. Therefore, it is important to establish causal relationships between the physiological changes that take place in apoptosis, because these are potential targets for novel treatment strategies to overcome this form of drug resistance. We describe the use of multilaser flow cytometry methods to make correlated measurements of mitochondrial membrane potential (MMP), the generation of reactive oxygen intermediates, the cellular content of reduced glutathione (GSH), intracellular calcium, and exposure of phosphatidylserine on the cell surface. Using these combined methods, we have mapped a "death sequence" that occurs after treatment of leukemic blasts with clinically relevant concentrations of 1-beta-D-arabinofuranosylcytosine (ara-C). Dual labeling of MMP and cellular glutathione content showed that loss of MMP, indicative of the permeability transition, took place in cells that were depleted of glutathione. The loss of MMP coincided with phosphatidylserine exposure and preceded a state of high reactive oxygen generation. Finally, there was an increase in intracellular calcium. These results demonstrate that the mitochondrial permeability transition takes place during ara-C toxicity but suggest that this occurs downstream of the loss of GSH. Thus, oxidative stress after ara-C-induced toxicity seems to be a biphasic phenomenon, with the permeability transition occurring after a depletion of GSH and preceding a state of high reactive oxygen generation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192824

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Suppression of the pro-apoptotic function of cytochrome c by singlet oxygen via a haem redox state-independent mechanism.

Authors:  Daisuke Suto; Kazuaki Sato; Yoshihiro Ohba; Tetsuhiko Yoshimura; Junichi Fujii
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

2.  Caspase-3-Dependent Cleavage of the Glutamate-L-Cysteine Ligase Catalytic Subunit during Apoptotic Cell Death.

Authors:  Christopher C Franklin; Cecile M Krejsa; Robert H Pierce; Collin C White; Nelson Fausto; Terrance J Kavanagh
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Bcl-2 expression causes redistribution of glutathione to the nucleus.

Authors:  D W Voehringer; D J McConkey; T J McDonnell; S Brisbay; R E Meyn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 4.  Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of Cardiotoxicity.

Authors:  Juan Tamargo; Ricardo Caballero; Eva Delpón
Journal:  Drug Saf       Date:  2022-01-13       Impact factor: 5.606

5.  Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.

Authors:  Roberto R Rosato; Jorge A Almenara; Sonia C Maggio; Stefanie Coe; Peter Atadja; Paul Dent; Steven Grant
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

6.  Radiation protection of HepG2 cells by Podophyllum hexandrum Royale.

Authors:  Damodar Gupta; Rajesh Arora; Amar Prakash Garg; Harish Chandra Goel
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

7.  Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress.

Authors:  M Hewish; S A Martin; R Elliott; D Cunningham; C J Lord; A Ashworth
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

8.  Cellular metabolism as a basis for immune privilege.

Authors:  M Karen Newell; Elizabeth Villalobos-Menuey; Susan C Schweitzer; Mary-Ellen Harper; Robert E Camley
Journal:  J Immune Based Ther Vaccines       Date:  2006-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.